Profile
Judith Segall is the founder of Lineage Cell Therapeutics, Inc. which was founded in 1990.
She held the title of Vice President-Administration from 2016 to 2019.
Currently, she is the Secretary & Director-Administration at AgeX Therapeutics, Inc. since 2017.
Ms. Segall has also worked as Secretary & Director at Asterias Biotherapeutics, Inc. and as Secretary at OncoCyte Corp.
Ms. Segall received her undergraduate degree from the University of California, Berkeley in 1989.
Former positions of Judith Segall
| Companies | Position | End |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Founder | 2019-07-31 |
| AGEX THERAPEUTICS, INC. | Chief Administrative Officer | - |
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Corporate Secretary | - |
| ASTERIAS BIOTHERAPEUTICS INC | Director/Board Member | - |
Training of Judith Segall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
- Stock Market
- Insiders
- Judith Segall
















